Angiodynamics (ANGO) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$11.0 million.
- Angiodynamics' Other Gross PP&E Adjustments fell 1009.92% to -$11.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$11.0 million, marking a year-over-year decrease of 1009.92%. This contributed to the annual value of $95.8 million for FY2025, which is 238.69% down from last year.
- Latest data reveals that Angiodynamics reported Other Gross PP&E Adjustments of -$11.0 million as of Q4 2025, which was down 1009.92% from -$11.2 million recorded in Q3 2025.
- Angiodynamics' 5-year Other Gross PP&E Adjustments high stood at $98.1 million for Q2 2024, and its period low was -$23.4 million during Q3 2021.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$11.2 million (2023), whereas its average is $12.0 million.
- In the last 5 years, Angiodynamics' Other Gross PP&E Adjustments surged by 4160.56% in 2024 and then crashed by 1009.92% in 2025.
- Over the past 5 years, Angiodynamics' Other Gross PP&E Adjustments (Quarter) stood at -$18.0 million in 2021, then increased by 16.59% to -$15.0 million in 2022, then rose by 24.6% to -$11.3 million in 2023, then rose by 11.61% to -$10.0 million in 2024, then fell by 10.1% to -$11.0 million in 2025.
- Its Other Gross PP&E Adjustments was -$11.0 million in Q4 2025, compared to -$11.2 million in Q3 2025 and $95.8 million in Q2 2025.